The Apollo Hospital group has partnered with Cellogen Therapeutics to conduct human trials for an indigenous dual antigen third-generation CAR-T cell therapy amid a bid by several health startups to develop affordable and accessible cancer treatments.
Read at
https://t.co/l1IjOJ0ZdU
by @Iam_Ayushmann | #ApolloHospital #CellogenTherapeutics #Cancer
#NewDelhi-based biotech startup Cellogen Therapeutics- working on cell based therapies - is planning to bring the new CAR-T cell cancer therapy to India and has inked an agreement with @IGIBSocial
https://t.co/LvmyLCdhKp
@CSIR_IND#CancerTherapeutics@DrGKharya